Tuberculosis in Ghana: treatment and control
Tuberculosis remains a serious but curable public health challenge in Ghana. Caused by Mycobacterium tuberculosis, an airborne bacterium that usually targets the lungs, the disease can be controlled through early diagnosis, effective treatment, contact investigation and measures that prevent drug-resistant infections from spreading. Ghana’s national tuberculosis program, delivered through the Ghana Health Service, combines case detection, laboratory testing, treatment and surveillance across the country to protect patients, families, schools, workplaces and wider communities.
For Australian readers, Ghana’s experience offers a sharp contrast with a country that has kept TB incidence comparatively low through notification, specialist treatment and contact management. Australian cases are concentrated among people born in high-incidence countries and their contacts, particularly in diverse cities such as Sydney, Melbourne and Brisbane. Certain visa applicants undergo immigration medical examinations that may include a chest X-ray, yet Australia’s low national rate should not obscure delayed diagnoses, local clusters or inequities affecting migrant, Aboriginal and Torres Strait Islander, and crowded-household communities.
Why tuberculosis remains a public health concern
Recent World Health Organization estimates place Ghana’s TB incidence in the hundreds per 100,000 people, far above Australia’s single-digit rate. The difference reflects variations in transmission, housing, nutrition, access to diagnosis and historically underfunded health systems rather than a simple division between safe and unsafe countries. Dense neighbourhoods in Accra and Kumasi, mining settlements, prisons and transport hubs can create conditions in which prolonged indoor contact and interrupted treatment increase risk.
TB spreads through the air when an infectious person coughs, sings or speaks, but everyday contact such as sharing a meal is not the main route. Persistent stigma, misinformation that the disease is untreatable and fear of isolation can delay care. Children and people with HIV, diabetes or undernutrition face greater danger of rapid progression, while BCG vaccination at birth helps prevent severe childhood TB without reliably preventing adult pulmonary disease.
Diagnosing and finding cases early
Diagnosis starts with symptoms such as a cough lasting two weeks or more, fever, night sweats, unexplained weight loss, fatigue or blood-streaked sputum, although some people have few symptoms. A chest X-ray can identify suspicious changes but cannot by itself confirm the cause. Sputum is tested with a GeneXpert molecular assay, which can identify M. tuberculosis and rifampicin resistance rapidly, while culture and drug-susceptibility testing confirm viability and resistance. Rapid results matter because every week of untreated infectious TB can expose others.
Once a case is found, health staff should review where and when the person was infectious, notify close contacts and arrange evaluation without waiting for symptoms. Household members, coworkers and residents of institutions may need screening, chest imaging, sputum tests or preventive treatment after active TB is excluded. Mobile teams and community health workers are valuable in remote areas, while stronger referral systems are needed in busy urban centres. Reliable electronic reporting helps managers identify clusters and move medicines and staff where demand is rising.
A six-month path to treatment
Treatment for most drug-susceptible pulmonary TB follows a six-month regimen: two months of isoniazid, rifampicin, pyrazinamide and ethambutol, followed by four months of isoniazid and rifampicin. Daily fixed-dose combinations simplify treatment and reduce missed or incorrect doses. Medicines are supplied through Ghana’s national program without direct charges to patients, but free drugs do not remove the cost of transport, lost wages, childcare or stigma. Stopping when symptoms improve is dangerous because relapse can follow, and missed or poorly absorbed medicines increase the risk of drug resistance.
Clinical follow-up checks symptoms, weight, sputum results and side effects while supporting full adherence. People with TB should also be offered HIV testing and prompt antiretroviral treatment where needed, alongside management of diabetes, nutrition and tobacco-related risks. Support can include counselling, community follow-up, flexible directly observed treatment where appropriate, and phone or digital adherence reminders. These services must fit patients’ lives, because respectful care and reliable treatment completion are central to interrupting transmission.
Controlling drug-resistant tuberculosis
Not every difficult case reflects drug resistance, but resistance must be identified early. Multidrug-resistant TB, or MDR-TB, is resistant at least to isoniazid and rifampicin and requires a different, more complex regimen. WHO-recommended options now use all-oral medicines, commonly including bedaquiline, with shorter courses for eligible patients than the older 18–24-month approaches. In Ghana, implementation depends on current national guidance, laboratory capacity and dependable supplies, so people with suspected resistant TB need specialist referral rather than an improvised continuation of first-line drugs.
Control extends beyond individual treatment. Clinics need rapid triage, ventilation, respiratory protection and fast laboratory results to reduce infection among patients and health workers. Public messaging should explain that TB is curable, discourage stigma and promote early evaluation of persistent coughs. Surveillance, contact investigation and treatment completion work together with wider action on housing, crowding, nutrition, HIV and smoking. Funding these elements together can reduce illness while weakening the reservoir of new infection.
Lessons for Australia and a practical way forward
Australia’s experience shows how a low TB rate can be maintained. State and territory health units investigate notifications within a national notifiable-disease framework, while public hospitals, Medicare and community health services support diagnosis and treatment. Multilingual campaigns and interpreters are especially important in Sydney, Melbourne and Brisbane, where some communities may have limited knowledge of or confidence in the health system. Australia also has a large retail medicine market, including chains such as Chemist Warehouse, although TB medicines are generally managed as specialist public-health treatments rather than routine retail purchases.
The two systems face different pressures, but several approaches are instructive:
| Feature | Ghana’s control approach | Australian reference point |
|---|---|---|
| Burden and surveillance | High estimated incidence requires sustained district-level detection and reporting | Low national incidence, but imported cases and local clusters still need investigation |
| Case finding | Symptom outreach, contact screening, chest imaging and GeneXpert testing in public facilities | Targeted screening among high-risk communities, overseas-born residents and people affected by outbreaks |
| Standard treatment | A six-month regimen provided through the national program at no direct medicine charge | Publicly funded specialist care, with Medicare helping cover eligible consultations and treatment |
| Drug resistance | Drug-susceptibility testing and referral to national or specialist services | Laboratory testing and specialist-led use of newer all-oral regimens |
| Community response | Stigma, travel costs and lost income can interrupt care | Multilingual education, interpreters and community health services help improve access and trust |
| Prevention | Improved ventilation, infection control, nutrition and management of HIV and diabetes | Rapid notification, contact management and targeted treatment prevent further transmission |
Support reliable local and international efforts by backing organisations that strengthen Ghana’s health system, including the Stop TB Partnership and Médecins Sans Frontières, and by encouraging Australian policymakers to maintain support for global TB programs. Media professionals, artists and creators can share Ghanaian public-health messages without sensationalising patients or exploiting images of illness. Supporters should also promote early clinical assessment rather than self-diagnosis and encourage treatment adherence among family members, friends and colleagues. Every completed course, earlier diagnosis and protected household weakens transmission.